PROF
- Profound Medical Corp.
()
Overview
Company Summary
Profound Medical Corp. is a medical technology company focused on developing and commercializing innovative solutions to treat prostate cancer and other diseases using magnetic resonance guided focused ultrasound (MRgFUS). Their proprietary platform, called TULSA-PRO, combines real-time MRI guidance with therapeutic ultrasound to precisely target and ablate diseased tissue while protecting surrounding healthy structures.
The TULSA-PRO system offers a minimally invasive, outpatient alternative for treating localized prostate cancer. This non-invasive technology enables physicians to deliver precise and personalized ablative therapy to the prostate, reducing the potential side effects often associated with traditional treatment methods like surgery or radiation therapy.
Profound Medical Corp.'s TULSA-PRO system has received regulatory approvals in multiple countries and is being actively commercialized. In addition to prostate cancer treatment, the company is exploring the potential of leveraging their MRgFUS technology to treat other conditions such as uterine fibroids and bone metastases.
By offering an innovative and precise treatment option, Profound Medical Corp. aims to make a significant impact on patient outcomes and improve the quality of life for individuals with prostate cancer and other diseases.